![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 34, 23702-23706, August 20, 1999
From the Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905
| |
ABSTRACT |
|---|
|
|
|---|
The utilization of blood glycerol and glucose as
precursors for intramuscular triglyceride synthesis was examined in
rats using an intravenous infusion of
[2-14C]glycerol and [6-3H]glucose or
[6-14C]glucose. In 24-h fasted rats, more glycerol than
glucose was incorporated into intramuscular triglyceride glycerol in
soleus (69 ± 23 versus 4 ± 1 nmol/µmol
triglyceride/h, respectively, p = 0.02 glycerol
versus glucose) and in gastrocnemius (25 ± 5 versus 9 ± 2 nmol/µmol triglyceride/h,
respectively, p = 0.02). Blood glucose was utilized
more than blood glycerol for triglyceride glycerol synthesis in
quadriceps. In fed rats, the blood glycerol incorporation rates (4 ± 2, 8 ± 3, and 9 ± 3 nmol/µmol triglyceride/h) were
similar (p > 0.3) to those of glucose (5 ± 2, 8 ± 2, and 5 ± 2 nmol/µmol triglyceride/h for quadriceps,
gastrocnemius, and soleus muscle, respectively). Glucose incorporation
into intramuscular triglycerides was less with
[6-3H]glucose than with [6-14C]glucose,
suggesting an indirect pathway for glucose carbon entry into muscle
triglyceride. The isotopic equilibrium between plasma and intramuscular
free glycerol ([U-13C]glycerol) was complete in
quadriceps and gastrocnemius, but not soleus, within 2 h after
beginning the tracer infusion. We conclude that blood glycerol is a
direct and important precursor for muscle triglyceride synthesis in
rats, confirming the presence of functionally important amounts of
glycerol kinase in skeletal muscle.
It is a biochemistry precept that the glycerol moiety of
triacylglycerols and phospholipids in non-hepatic mammalian tissues is
primarily derived from glucose via glycolysis (1). Dihydroxyacetone phosphate (DHAP),1
originating from glucose, is reduced to glycerol 3-phosphate (G3P) by
the action of glycerophosphate dehydrogenase. G3P then undergoes
sequential acylation steps to incorporate three fatty acids to form a
triacylglycerol (TG) (2). DHAP can also take a different path (DHAP
pathway) via 1-acyldihydroxyacetone phosphate and then 1-acylglycerol
3-phosphate, but this appears to be a quantitatively minor reaction (3,
4). Glycerol can be converted directly to G3P by glycerol kinase, but
this is believed to occur primarily, if not solely, in the liver and
kidney because the glycerol kinase activity in these tissues is
sufficient to permit large quantities of blood glycerol to be used for
gluconeogenesis and TG synthesis. The direct conversion of free
glycerol to G3P is thought to be negligible in skeletal muscle and
adipose tissue because of their low activities of glycerol kinase
(5-8). A corollary to this supposition is that glycerol generated by
the hydrolysis of TG in skeletal muscle quantitatively enters the
circulation. These assumptions form the basis for using systemic
glycerol appearance rate, measured by isotope dilution techniques, as a
quantitative measure of whole body lipolysis (9, 10).
The presence of small but measurable glycerol kinase activity in
skeletal muscle of various animal species, including rat (5) and humans
(6), raises concerns as to the validity of these assumptions, however.
For example, although low in specific activity, skeletal muscle
glycerol kinase could be important in the metabolism of circulating
glycerol considering the mass of this tissue. Reports of
tracer-determined glycerol uptake across human forearm (11, 12) suggest
skeletal muscle may utilize glycerol, although it has been argued that
this represents isotope disequilibrium rather than true uptake. Whether
the glycerol kinase activity that is observed in mammalian skeletal
muscle is functionally important has not been addressed, nor has the
downstream intracellular fate of the G3P generated from blood glycerol.
These studies were designed to test the hypothesis that skeletal muscle
utilizes blood glycerol for intracellular TG glycerol synthesis. We
also measured the rate of glycerol incorporation into TG by muscle
groups of different fiber types and compared glycerol to blood glucose
as a substrate for TG glycerol biosynthesis.
Animals and Experiments
Experiment 1--
Male Harlan Sprague-Dawley rats (body weight
350 g) were fed ad libitum (n = 5) or
fasted for 24 h (n = 5) before the studies. The
rats were conditioned in a rat restraint cage with wire floor for 30 min prior to study. [2-14C]Glycerol and
[6-3H]glucose (DuPont) were infused for 3 h via a
tail vein at ~0.04 µCi/min (the exact infusion rate in each animal
was determined) using a Terumo infusion set with a 25-gauge × 3/4-inch needle (Terumo Medical Corp., Elkton, MD). After 3 h of
the tracer infusions, pentobarbital (30 mg/kg) was injected through the
infusion line to lightly anesthetize the animal. Arterial blood samples
were collected by cardiopuncture, and the plasma was separated by
centrifugation at 3000 rpm for 15 min. Immediately after the blood was
taken, more pentobarbital was injected (200 mg/kg) to euthanize the
rats. Quadriceps, lateral gastrocnemius, and soleus muscles were
quickly removed and washed of blood elements in 0.9% saline. The
muscle samples were placed in 2-ml polyethylene microcentrifuge tubes, immediately merged in liquid N2, and stored at Experiment 2--
To assess the suitability of
[6-3H]glucose as a tracer for glycerogenesis, separate
experiments were performed in which [6-14C]- and
[6-3H]glucose were infused simultaneously without
[2-14C]glycerol in three fasted rats and
[6-14C]glucose was infused alone in three fed rats.
Muscle and blood samples were collected and processed as described for
Experiment 1.
Experiment 3--
To evaluate whether glycerol equilibrates
between plasma and intramuscular compartments,
[U-13C]glycerol was infused intravenously at 0.2 µmol/min for 3 h in five fasted rats using the same protocol,
except a base-line blood sample (to measure background enrichment) was
collected through a tail vein before beginning the infusion. Additional
experiments were conducted to determine the time course of isotopic
equilibration between plasma glycerol and intramuscular free glycerol
pools. Three rats were infused with [U-13C]glycerol for
1 h and another three rats for 2 h. The 13C
enrichment of plasma and muscle free glycerol were measured on samples
collected at the end of the tracer infusion.
Determination of Plasma Glycerol and Glucose specific
Activities (SA)
Plasma was deproteinized with 0.3 M BaOH and 0.3 M ZnSO4 (1:1:1, v/v/v) and the supernatant
loaded on ion-exchange column (AG 1X8, hydroxide form, 200-400-mesh)
(Bio-Rad). Glycerol was eluted with 4 ml of deionized water and then
glucose with 4 ml of 1 N NaCl. The
[14C]glycerol SA was measured by HPLC (13) or by an
enzymatic method (14). Plasma glycerol concentration was determined
using the same enzymatic method. Plasma glucose concentration was
determined using a glucose analyzer (Beckman, Palo Alto, CA), and
glucose SA was determined by counting the glucose samples on a liquid scintillation counter.
Determination of Glycerol and Glucose Incorporation into
Muscle Triacylglycerol
Frozen muscle samples were pulverized into fine powder (~50
µm) at Evaluation of Glycerol Equilibration between Plasma and
Muscle Compartments
Plasma samples from the [U-13C]glycerol infusion
experiments were processed chromatographically as described above.
Muscle free glycerol was obtained from aqueous phase of a Folch lipid
extract. The aqueous phase was air blow-dried and dissolved in water,
loaded on ion-exchange column, and glycerol eluted with water. Purified plasma and muscle free glycerol was derivatized to triacetyl glycerol in 200 µl of pyridine and acetyl anhydride (1:1, v/v) at 70 °C for
60 min. The glycerol derivative was analyzed by gas
chromatography/combustion/isotope ratio mass spectrometry for
13C enrichment. The gas chromatograph (GC; Hewlett Packard,
model 5890) was equipped with a DB-5 MS capillary column (30 m × 0.32 mm inner diameter, 0.25 µm film) (J&W Scientific, Folsom, CA). The GC
oven temperature was programmed initially at 80 °C for 0.5 min, and
increased to 200 °C at 20 °C/min and then to 300 °C at
35 °C/min and stayed at 300 °C for 3 min. The GC was
electronically controlled for constant pressure and humidity. Details
of isotope ratio mass spectrometry operation were as described
previously (17). 13C enrichment was expressed as atom % excess. The ratio of 13C enrichment of muscle free glycerol
to that of plasma glycerol was calculated and used as an index of
glycerol equilibration between these two compartments (a ratio of 1 indicates complete equilibration).
Calculation of Glycerol and Glucose Appearance Rate
The infusion rate (dpm/min) of [2-14C]glycerol and
[6-3H]glucose was divided by SA (dpm/µmol) of plasma
glycerol and glucose, respectively, to give the appearance rates
(µmol/min).
Calculation of Blood Glycerol and Glucose
Incorporation Rates into Muscle TG
Incorporation rates were calculated by dividing the SA of plasma
glycerol or glucose (dpm/µmol) by the total radioactivity (dpm) of
the intramuscular TG glycerol moiety. In experiment 1, appreciable
amounts of [14C]glycerol were converted to
[14C]glucose (Table I) via gluconeogenesis, implying that
the 14C present in muscle TG glycerol could originate both
from glucose and glycerol. We initially planned to use
[6-3H]glucose to trace glucose incorporation into TG
glycerol; however, this approach was found to be unsatisfactory (see
below). The indirect glycerol incorporation into muscle TG glycerol via
glucose was therefore calculated by multiplying the plasma glucose
14C SA in experiment 1 (Table I) by the glucose
incorporation rate determined using [6-14C]glucose
(experiment 2; conducted under identical conditions). The results were
then subtracted from the apparent glycerol incorporation rates to
determine those directly attributable to glycerol. The incorporation
rates of blood glycerol are given as those after the correction for
indirect contribution via glucose. Glucose incorporation rate is given
as that determined using [6-14C]glucose as well as using
[6-3H]glucose. Each glucose molecule can potentially
contribute 2 molecules of TG glycerol; therefore, to compare glycerol
and glucose on a carbon equivalent basis, it is necessary to double the
apparent glucose values. Because blood was sampled only at the end of
tracer infusion, it was necessary to assume that the SA of plasma
glycerol and glucose were at steady state for the duration of infusion. This seems a reasonable assumption, considering the very brief half-life of circulating glycerol (18); however, it is unlikely that
the [14C]glucose SA in experiment 1 was at steady state
because of the gradual incorporation of [14C]glycerol
into [14C]glucose. Therefore, the rates of indirect
[14C]glycerol incorporation into intramuscular TG
glycerol via glucose in experiment 1 (above) are likely to be
overestimates. The incorporation rates are expressed on a per hour
basis assuming the incorporation was linear during the 3-h tracer infusion.
Calculation of Loss of 3H Label from Glucose
(Indirect Glycerogenesis)
This is calculated as the difference from unit in the ratio of
glucose incorporation rate determined by [6-3H]glucose to
that by [6-14C]glucose (1 Statistics
All values are expressed as mean ± S.E. Analysis of
variance was used to detect difference between three muscle groups, and paired, one-tailed Student's t test for comparison between
two muscles, if appropriate, to test for differences in a specific direction based upon previous work (17). Two-tailed, unpaired Student's t test was used for comparisons between glycerol
and glucose parameters.
Glycerol and Glucose Kinetics--
The infusion rates of
[2-14C]glycerol and [6-3H]glucose, the
plasma glycerol and glucose concentration and SA values, and glycerol and glucose appearance rates for experiment 1 are presented in Table
I. Plasma glycerol concentrations in
fasted rats were 33% greater (p < 0.01) than that in
fed rats, as were glycerol appearance rates (p < 0.05). Plasma glucose concentrations were modestly but significantly
(p < 0.05) lower in fasted than in fed rats, but
systemic glucose appearance rates were not significantly different. Substantial amounts of 14C were present in plasma glucose,
more so in fasted than in fed rats, indicating active glycerol to
glucose production via gluconeogenesis.
Incorporation of Glycerol and Glucose into Skeletal Muscle TG
Glycerol Moiety--
Table II provides
the rates of blood glycerol (experiment 1) and glucose (experiment 2)
incorporation into intramuscular TG glycerol; the glycerol values are
corrected for the 14C incorporation calculated to have come
via [14C]glucose (Table I). In fasted rats the relative
contributions of glycerol and glucose to muscle TG glycerol synthesis
varied between muscles. In soleus, a slow twitch oxidative muscle,
glycerol was incorporated at a rate 16-fold greater than that of
glucose (69 ± 23 versus 4.4 ± 0.7 nmol/µmol of
TG/h, respectively, p = 0.02). The difference remained
significant when the rates were compared on a carbon-equivalent basis
(p = 0.02). The same pattern was noted in gastrocnemius
(glycerol > glucose on a molar basis, p = 0.02).
When compared on a carbon-equivalent basis (24.5 versus 18.6 nmol of glycerol equivalents/µmol of TG/h for glycerol and glucose,
respectively), the difference between glycerol and glucose was no
longer statistically significant (p = 0.2). On a molar basis quadriceps utilized glucose and glycerol for intramuscular TG
glycerol synthesis at similar (p = 0.7) rates, however,
on a carbon-equivalent basis, the incorporation rate of glucose was greater (p = 0.02) than that of glycerol (17.2 versus 7.3 nmol of glycerol equivalents/µmol of TG/h,
respectively).
In fed rats, the incorporation rates of glycerol and glucose in
quadriceps and gastrocnemius were similar both on a molar basis and on
a carbon-equivalent basis. In soleus, the molar contribution of blood
glucose to TG glycerol synthesis was approximately one-half of that of
blood glycerol (p = 0.3), and the carbon-equivalent contributions of blood glycerol and glucose were equal (8.5 and 9.2 nmol of glycerol equivalents/µmol of TG/h, respectively,
p = 0.9).
Blood glycerol incorporation rates into soleus and gastrocnemius TG
glycerol in fasted rats were 8- and 3-fold, respectively, greater
(Table II) than their rates in fed rats (p < 0.03),
whereas those in quadriceps were similar (p = 0.25). In
contrast, incorporation rates of glucose under fed and fasted
conditions were similar in all three muscles (p > 0.14).
Comparison of [6-3H]Glucose and
[6-14C]Glucose to Trace Intramuscular TG Glycerol
Synthesis--
We originally used [6-3H]glucose to trace
the incorporation of glucose into intramuscular TG glycerol, reasoning
that the 3H on carbon 6 of glucose would be retained during
the formation of G3P from blood glucose within the muscle (19). In
experiment 1, we found almost no incorporation of 3H into
intramuscular TG glycerol, suggesting minimal glucose utilization for
this pathway. To address concerns that this could be an isotope exchange problem, experiment 2 was undertaken. We found that the rates
of glucose incorporation into intramuscular TG glycerol determined by
[6-3H]glucose were much less than those determined using
[6-14C]glucose (Table II). In fasted rats, the vast
majority of 3H (relative to 14C) was lost in
the conversion of glucose to TG glycerol in each muscle group. In fed
rats, the 3H losses from glucose ranged from 62% to 90%
compared with 14C (Table II).
Because of gluconeogenesis in fasted rats, a substantial amount of
glycerol carbon could have been incorporated into muscle TG glycerol
via glucose. This indirect contribution of glycerol carbons was most
marked in quadriceps of fasted rats with an indirect to direct ratio of
1.35. The ratios for gastrocnemius and soleus were 0.4 and 0.07, respectively. In fed rats, the difference in the ratios among the three
muscle groups were not as substantial as in fasted rats, ranging from
0.27 in soleus to 0.62 in quadriceps (Table II).
Isotopic Equilibrium between Plasma and Muscle Free Glycerol
Pools--
Glycerol isotopic ([U-13C]glycerol)
equilibration between plasma and intramuscular free glycerol pools was
evaluated using as an index the ratio of 13C enrichment
(atom % excess) of muscle free glycerol to plasma glycerol at the end
of [U-13C]glycerol infusion. The results are shown in
Fig. 1. By the end of 1 h of tracer
infusion, 13C enrichments of quadriceps, gastrocnemius, and
soleus free glycerol were only 40-70% of that of plasma glycerol. By
the end of 2 h of infusion, an isotopic equilibrium had achieved
in quadriceps and gastrocnemius with a ratio essentially equal to 1.0. However, soleus free glycerol did not reach a full equilibrium with
plasma glycerol even after 3 h of infusion (~70% of that of
plasma at this time). At both 1 and 2 h, but not 3 h, of
tracer infusion, 13C enrichment ratio of muscle free
glycerol to plasma glycerol in soleus muscle was significantly lower
than those in other two muscles (p < 0.05).
These studies examined whether blood glycerol is a direct
precursor for intramuscular TG glycerol synthesis in a rat model. It
has been long thought that triglycerides acquire their glycerol moiety
primarily from glucose via DHAP (1, 4). Although there have been
debates over relative contributions of G3P pathway versus
DHAP pathway to triglyceride and phospholipid synthesis (3, 4), the
possibility that glycerol itself is a significant precursor of
intramuscular TG glycerol synthesis does not appear to have been
explored. Glycerol kinase directly activates glycerol to G3P for
acylation, and it seemed reasonable to believe that tissues low in
glycerol kinase activity, such as skeletal muscle, rely on glucose for
the synthesis of TG glycerol. However, results from the present study
suggest this is not the case. Even in fed rats, where glycerol is less
available and glucose is more abundant, the glycerol incorporation rate
into muscle triglyceride was comparable to that of glucose on a
carbon-equivalent basis. In fasted rats, the rate of blood glycerol
incorporation into muscle TG glycerol was much greater than that of
glucose, especially in soleus, a primarily oxidative muscle. On the
other hand, glucose was the predominant precursor for muscle TG
glycerol synthesis in quadriceps, consistent with conventional belief
as described above. Thus, in fasted rats, a pattern was observed that
the preference of blood glycerol over blood glucose for TG glycerol
synthesis in skeletal muscle is consistent with the muscles' oxidative
capacity (soleus > gastrocnemius > quadriceps).
The rat soleus muscle has greater intracellular TG content (17) and
oxidative capacity (20) than gastrocnemius and quadriceps muscles. We
found that soleus can also utilize greater amount of blood glycerol. In
contrast, quadriceps, a fast twitch, glycolytic muscle (21), has a
triglyceride content one-fifth of that of soleus (17, 22), and its
utilization of blood glycerol for fatty acid esterification appears
limited. Since quadriceps relies on glycolysis to a greater extent for
ATP production, it seems logical for it to use more blood glucose than
glycerol as a precursor for TG glycerol. The rat lateral gastrocnemius
contains both glycolytic and oxidative muscle fibers (21), and has an
intermediate capacity to utilizing blood glycerol for fatty acid
esterification. We conclude that utilization of blood glycerol for
intramuscular TG glycerol synthesis is related to the ability of muscle
to oxidize and store fatty acids. The preference of glycerol over
glucose for muscle TG glycerol synthesis in type I fiber-rich muscle
suggests that its glycerol kinase activity is higher than in other
muscle types (5).
Another possible reason for the greater use of blood glycerol for TG
synthesis by soleus muscle is a lesser activity of glycerophosphate dehydrogenase, the enzyme responsible for the conversion of DHAP to
G3P. This might explain the limited flow of glucose carbons to G3P and
hence to TG glycerol we observed in some muscle groups. Indeed, the
activity of cytosolic glycerophosphate dehydrogenase in skeletal muscle
is at least 2-3 times lower than that of liver in rats (23, 24). In
addition, due to oxidative shift of redox status as a result of fasting
(25), a high NAD+/NADH ratio in fasted rats may have
inhibited glucose incorporation into muscle TG glycerol because it
favors the equilibrium from G3P to DHAP.
Although glycerol kinase activity in skeletal muscle (5, 6) is much
less than that in the liver, this appears to be only a relative
limitation. The mammalian intramuscular TG pool size is generally
small, usually up to a few micromoles/g of wet muscle (17, 26). The
enzyme activity in rat muscle, 7 nmol/g of wet muscle/min (5), could
account for substantial glycerol utilization, i.e. 0.42 µmol/g of wet muscle/h. This rate of utilization is almost the same
as the size of the entire pool of intramuscular triglycerides in some
predominantly fast twitch, glycolytic muscles such as gastrocnemius and
quadriceps. The enzyme activity in human muscle is similar to the rat,
or 9 nmol/g/min (6), and thus could provide 15 mmol/h of G3P for TG
synthesis (assuming 40% of a 70-kg body mass as skeletal muscle). This
value exceeds the glycerol appearance rate in adult humans (~150
µmol/min). Thus, glycerol kinase could play a greater role in
skeletal muscle lipid metabolism than previously realized.
In present studies, the rate of incorporation of blood glycerol into
intramuscular TG glycerol in fasted rats was ~0.4 and ~6 nmol/g of
wet muscle/min for gastrocnemius and soleus muscle, respectively. In a
previous study using the same experimental conditions (17), we found
the synthesis rates of intramuscular TG for gastrocnemius and soleus to
be 2.3 and 3.8 nmol/g of wet muscle/min, respectively, using fatty acid
tracers. This suggests that, for the soleus muscle, blood glycerol
provides the vast majority of the backbone of intramuscular TG. It
appears that blood glycerol and glucose make a substantial (~20%
each) contribution to intramuscular TG synthesis in the gastrocnemius.
The source of the remaining TG glycerol is not clear, but glycolysis of
muscle glycogen-derived glucose may provide TG glycerol carbons.
Another possibility is glycerogenesis from other three carbon
intermediates. The virtually complete loss of 3H label
relative to 14C from blood glucose in muscle TG glycerol
implies that glucose had gone through pyruvate carboxylase catalyzed
reactions (27, 28), and therefore gluconeogenic precursors could
have made their way to triglyceride glycerol as well.
We obtained evidence for indirect glycerogenesis from blood glucose, as
indicated by the extensive loss of 3H label from
[6-3H]glucose. This suggests that the majority of blood
glucose destined for TG glycerol arrived at G3P from steps further down
the glycolytic pathways. Presumably, glucose has gone through
pyruvate/lactate stage before making its way to G3P via
gluconeogenesis, during which hydrogen atoms at the 6th carbon position
are lost (19, 27, 28). This is the only explanation for the loss of
3H labels from [6-3H]glucose. In the
interconversion of pyruvate and alanine, although 6-3H of
glucose is lost (19), the three-carbon metabolite has to undergo
gluconeogenesis via oxaloacetate in order to return to DHAP because
phosphoenolpyruvate We observed a moderate delay in isotopic equilibration between plasma
and muscle free glycerol pools. In quadriceps and gastrocnemius muscles, the equilibration was complete by 2 h of tracer infusion. In the soleus, on the other hand, a full isotopic equilibrium was not
observed even after 3 h of tracer infusion. At 1 and 2 h of
infusion, the 13C enrichment of soleus free glycerol was
significantly lower than that in other two muscles. The difference in
isotopic equilibration between this oxidative muscle and other more
glycolytic muscles suggests that TG-fatty acid cycling in soleus is
active (30). Free glycerol generated from such cycling may have diluted
incoming [13C]glycerol because TG content (thus the
amount of glycerol generated) in soleus is 5 times higher than that in
other two muscles (17). Overall, glycerol isotopic equilibration
between plasma and intramuscular pools appears slow. For a small
molecule like glycerol, this seems unexpected. Nonetheless, this is
consistent with the reported direction of the concentration gradient
transport of glycerol in skeletal muscle (12, 31).
In summary, rat skeletal muscle has a greater capacity for utilizing
blood glycerol for intracellular TG synthesis than previously realized.
Blood glycerol may be a preferred substrate for TG glycerol synthesis
in fasted rats depending on the muscle's oxidative capacity. In fed
rats, blood glycerol and glucose contribute similar amounts of carbons
to muscle TG glycerol synthesis. The utilization of blood glycerol for
this pathway appears to be substrate-regulated, whereas glucose is
probably more of a constitutive substrate.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
80 °C
for later analysis.
80 °C using a stainless steel mortar and pestle. Muscle lipids were extracted (15), and triglycerides were purified by HPLC
(16). The triglycerides were saponified using 1 N KOH in
90% methanol at 70 °C for 60 min and acidified with 5 N
H2SO4, and fatty acids were extracted with
hexane. The aqueous phase containing glycerol was air blow-dried at
40 °C, and 14C and 3H activities determined
by liquid scintillation counter. Glycerol concentration was determined
enzymatically (14).
glucose
incorporation[6-3H]glucose/glucose incorporation[6-14C]glucose).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Tracer infusion rates, SA, and rate of appearance of plasma glycerol
and glucose
Rates of incorporation of plasma glycerol and glucose into muscle
triglyceride glycerol

View larger version (17K):
[in a new window]
Fig. 1.
Isotopic equilibration between plasma and
intramuscular free glycerol pools in rats.
[U-13C]Glycerol was intravenously infused for periods as
indicated, and muscles were biopsied and blood collected at the end of
infusion. Free glycerol was isolated from plasma and muscles,
13C enrichment determined by gas
chromatography/combustion/isotope ratio mass spectrometry, and ratios
of 13C enrichments of muscle to plasma calculated. Each
time point represents three experiments for 1 and 2 h and 5 experiments
for 3 h.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
pyruvate reaction is irreversible (1). This
indirect pathway has been established for glycogen synthesis by the
liver (29) but not in skeletal muscle.
| |
ACKNOWLEDGEMENT |
|---|
We thank Rita Nelson for assistance in HPLC analysis of plasma glycerol specific activity.
| |
FOOTNOTES |
|---|
* This work was supported by Grant DK40484 from the United States Public Health Service, by the Minnesota Obesity Center (National Institutes of Health Grant DK50456), and by the Mayo Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom all correspondence and reprint requests should be
addressed: Endocrine Research Unit, 5-194 Joseph, Mayo Clinic,
Rochester, MN 55905. Tel.: 507-255-6768; Fax: 507-255-4828; E-mail:
jensen.michael@mayo.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: DHAP, dihydroxyacetone phosphate; G3P, glycerol 3-phosphate; TG, triacylglycerol; SA, specific activity; HPLC, high performance liquid chromatography; GC, gas chromatograph.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Stryer, L. (1981) Biochemistry , pp. 457-479, W. H. Freeman and Co., New York |
| 2. | Mayes, P. A. (1988) Harper's Biochemistry: A Lange Medical Book , pp. 218-225, Appleton & Lange, Norwalk, CT |
| 3. | Rognstad, R., Clark, D. G., and Katz, J. (1974) Biochem. J. 140, 249-251[Medline] [Order article via Infotrieve] |
| 4. | Pollock, R. J., Hajra, A. K., and Agranoff, B. W. (1975) Biochim. Biophys. Acta 380, 421-435[Medline] [Order article via Infotrieve] |
| 5. | Newsholme, E. A., and Taylor, K. (1969) Biochem. J. 112, 465-474[Medline] [Order article via Infotrieve] |
| 6. | Seltzer, W. K., Angelini, C., Khariwal, G., Ringel, S., and McCabe, E. R. B. (1989) Muscle Nerve 12, 307-313[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Robinson, J., and Newsholme, E. A. (1967) Biochem. J. 104, 2C[Medline] [Order article via Infotrieve] |
| 8. | Ryall, R. L., and Goldrich, R. B. (1977) Lipids 12, 272-277[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Kurpad, A., Khan, K., Calder, A. G., Coppack, S. W., Frayn, K. N., Macdonald, I. A., and Elia, M. (1994) Clin. Sci. 86, 177-184[Medline] [Order article via Infotrieve] |
| 10. | Nurjhan, N., Kennedy, F., Consoli, A., Martin, C., Miles, J., and Gerich, J. (1988) Metabolism 37, 386-389[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Elia, M., Khan, K., Calder, G., and Kurpad, A. (1993) Clin. Sci. 84, 99-104[Medline] [Order article via Infotrieve] |
| 12. | Samra, J. S., Ravell, C. L., Giles, S. L., Arner, P., and Frayn, K. N. (1996) Clin. Sci. 90, 453-456[Medline] [Order article via Infotrieve] |
| 13. |
Judd, R. L.,
Nelson, R.,
Klein, S.,
Jensen, M. D.,
and Miles, J.
(1998)
J. Lipid Res.
39,
1106-1110 |
| 14. | Humphreys, S. M., Fisher, R. M., and Frayn, K. N. (1990) Ann. Clin. Biochem. 27, 597-598 |
| 15. |
Folch, J.,
and Lees, M.
(1957)
J. Biol. Chem.
226,
497-509 |
| 16. | Christie, W. W. (1985) J. Lipid Res. 26, 507-512[Abstract] |
| 17. |
Guo, ZK,
and Jensen, M. D.
(1998)
J. Appl. Physiol.
84,
1674-1679 |
| 18. | Beylot, M., Martin, C., Beaufrere, B., Riou, J. P., and Mornex, R. (1987) J. Lipid. Res. 28, 414-422[Abstract] |
| 19. | Landau, B. R. (1993) Metabolism 42, 457-462[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Saltin, B., Henriksson, J., Nygaard, E., and Andersen, P. (1977) Ann. N. Y. Acad. Sci. 301, 3-29[Abstract] |
| 21. |
Maltin, C. A.,
Delday, M. I.,
Baillie, A. G.,
Grubb, D. A.,
and Garlick, P. J.
(1989)
Am. J. Physiol.
257,
E823-E827 |
| 22. | Frayn, K. N., and Maycock, P. F. (1980) J. Lipid Res. 21, 139-144[Abstract] |
| 23. | Holloszy, J. O., and Oscai, L. B. (1969) Arch. Biochem. Biophys. 130, 653-656[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | Harding, J. W., Jr., Pyeritz, E. A., Morris, H. P., and White, H. B., III (1975) Biochem. J. 148, 545-550[Medline] [Order article via Infotrieve] |
| 25. | Zahlten, R. N., Nejtek, M. E., and Jacobsen, J. C. (1982) Arch. Biochem. Biophys. 213, 200-231[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Gorski, J. (1992) Can. J. Physiol. Pharmacol. 70, 123-131[Medline] [Order article via Infotrieve] |
| 27. | Rognstad, R., Clark, G., and Katz, J. (1974) Eur. J. Biochem. 47, 383-388[Medline] [Order article via Infotrieve] |
| 28. | Guo, ZK, Lee, W. N., Katz, J., and Bergner, A. E. (1992) Anal. Biochem. 204, 273-282[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Kurland, I. J., and Pilkis, S. J. (1989) FASEB J. 3, 2277-2281[Abstract] |
| 30. | Tagliaferro, A. R., Dobbin, S., Curi, R., Leighton, B., Meeker, L. D., and Newsholme, E. A. (1990) Int. J. Obes. 14, 957-971[Medline] [Order article via Infotrieve] |
| 31. | Rosdahl, H., Hamrin, K., Ungerstedt, U., and Henriksson, J. (1998) Am. J. Physiol. 274, E936-E945 |
This article has been cited by other articles:
![]() |
C. Moro, S. Bajpeyi, and S. R. Smith Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E203 - E213. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Wallis, A. L. Friedlander, K. A. Jacobs, M. A. Horning, J. A. Fattor, E. E. Wolfel, G. D. Lopaschuk, and G. A. Brooks Substantial working muscle glycerol turnover during two-legged cycle ergometry Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E950 - E957. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Guo, L. Zhou, and M. D. Jensen Acute hyperinsulinemia inhibits intramyocellular triglyceride synthesis in high-fat-fed obese rats J. Lipid Res., December 1, 2006; 47(12): 2640 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Kinman, T. Kasumov, K. A. Jobbins, K. R. Thomas, J. E. Adams, L. N. Brunengraber, G. Kutz, W.-U. Brewer, C. R. Roe, and H. Brunengraber Parenteral and enteral metabolism of anaplerotic triheptanoin in normal rats Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E860 - E866. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Horton, E. K. Miller, and K. Bourret No effect of menstrual cycle phase on glycerol or palmitate kinetics during 90 min of moderate exercise J Appl Physiol, March 1, 2006; 100(3): 917 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Qvisth, E. Hagstrom-Toft, S. Enoksson, E. Moberg, P. Arner, and J. Bolinder Human Skeletal Muscle Lipolysis Is More Responsive to Epinephrine Than to Norepinephrine Stimulation in Vivo J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 665 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Cha, T. P. Ciaraldi, K.-S. Park, L. Carter, S. R. Mudaliar, and R. R. Henry Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPAR{gamma} agonists Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E151 - E159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Enoksson, E. Hagstrom-Toft, J. Nordahl, K. Hultenby, N. Pettersson, B. Isaksson, J. Permert, R. Wibom, C. Holm, J. Bolinder, et al. Marked Reutilization of Free Fatty Acids during Activated Lipolysis in Human Skeletal Muscle J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1189 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sacchetti, B. Saltin, D. B Olsen, and G. van Hall High triacylglycerol turnover rate in human skeletal muscle J. Physiol., December 15, 2004; 561(3): 883 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Zderic, S. Schenk, C. J. Davidson, L. O. Byerley, and E. F. Coyle Manipulation of dietary carbohydrate and muscle glycogen affects glucose uptake during exercise when fat oxidation is impaired by {beta}-adrenergic blockade Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1195 - E1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Qvisth, E. Hagstrom-Toft, S. Enoksson, R. S. Sherwin, S. Sjoberg, and J. Bolinder Combined Hyperinsulinemia and Hyperglycemia, But Not Hyperinsulinemia Alone, Suppress Human Skeletal Muscle Lipolytic Activity in Vivo J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4693 - 4700. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Zderic, C. J. Davidson, S. Schenk, L. O. Byerley, and E. F. Coyle High-fat diet elevates resting intramuscular triglyceride concentration and whole body lipolysis during exercise Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E217 - E225. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Reshef, Y. Olswang, H. Cassuto, B. Blum, C. M. Croniger, S. C. Kalhan, S. M. Tilghman, and R. W. Hanson Glyceroneogenesis and the Triglyceride/Fatty Acid Cycle J. Biol. Chem., August 15, 2003; 278(33): 30413 - 30416. [Full Text] [PDF] |
||||
![]() |
W. T. L. Festuccia, R. Guerra-Sa, N. H. Kawashita, M. A. R. Garofalo, E. A. Evangelista, V. Rodrigues, I. C. Kettelhut, and R. H. Migliorini Expression of glycerokinase in brown adipose tissue is stimulated by the sympathetic nervous system Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1536 - R1541. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Moberg, S. Sjoberg, E. Hagstrom-Toft, and J. Bolinder No apparent suppression by insulin of in vivo skeletal muscle lipolysis in nonobese women Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E295 - E301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sjostrand, S. Gudbjornsdottir, A. Holmang, L. Strindberg, K. Ekberg, and P. Lonnroth Measurements of Interstitial Muscle Glycerol in Normal and Insulin-Resistant Subjects J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2206 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. H. Kawashita, W. T. L. Festuccia, M. N. Brito, M. A. F. Moura, S. R. C. Brito, M. A. R. Garofalo, I. C. Kettelhut, and R. H. Migliorini Glycerokinase activity in brown adipose tissue: a sympathetic regulation? Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1185 - R1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Lee, A. S. Deonarine, M. Kienetz, Q. Zhu, M. Skrzypczak, M. Chan, and P. C. Choy A novel pathway for lipid biosynthesis: the direct acylation of glycerol J. Lipid Res., December 1, 2001; 42(12): 1979 - 1986. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Voshol, M. C. Jong, V. E.H. Dahlmans, D. Kratky, S. Levak-Frank, R. Zechner, J. A. Romijn, and L. M. Havekes In Muscle-Specific Lipoprotein Lipase-Overexpressing Mice, Muscle Triglyceride Content Is Increased Without Inhibition of Insulin-Stimulated Whole-Body and Muscle-Specific Glucose Uptake Diabetes, November 1, 2001; 50(11): 2585 - 2590. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Carter, C. Rennie, and M. A. Tarnopolsky Substrate utilization during endurance exercise in men and women after endurance training Am J Physiol Endocrinol Metab, June 1, 2001; 280(6): E898 - E907. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Burelle, D. Massicotte, M. Lussier, C. Lavoie, C. Hillaire-Marcel, and F. Peronnet Oxidation of [13C]glycerol ingested along with glucose during prolonged exercise J Appl Physiol, May 1, 2001; 90(5): 1685 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Coyle, A. E. Jeukendrup, M. C. Oseto, B. J. Hodgkinson, and T. W. Zderic Low-fat diet alters intramuscular substrates and reduces lipolysis and fat oxidation during exercise Am J Physiol Endocrinol Metab, March 1, 2001; 280(3): E391 - E398. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Montell, C. Lerin, C. B. Newgard, and A. M. Gomez-Foix Effects of Modulation of Glycerol Kinase Expression on Lipid and Carbohydrate Metabolism in Human Muscle Cells J. Biol. Chem., January 18, 2002; 277(4): 2682 - 2686. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||